(Q35037363)

5 August 2017

1 reference

title

Primary prevention of uterine cervix cancer: focus on vaccine history and current strategy (English)

1 reference

5 August 2017

2

Philip John DiSaia

0 references

author name string

Krishnansu Sujata Tewari

series ordinal

1

1 reference

5 August 2017

publication date

1 December 2002

1 reference

Obstetrics and Gynecology Clinics of North America

5 August 2017

published in

1 reference

5 August 2017

volume

29

1 reference

5 August 2017

issue

4

1 reference

5 August 2017

page(s)

843-68, ix

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2802%2900046-3

5 August 2017

1 reference

7 January 2021

Rhazes. The original portrayer of smallpox.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2802%2900046-3

7 January 2021

Two hundred years on: Jenner and the discovery of vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2802%2900046-3

7 January 2021

The genesis of Edward Jenner's Inquiry of 1798: a comparison of the two unpublished manuscripts and the published version

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2802%2900046-3

7 January 2021

Smallpox: the triumph over the most terrible of the ministers of death

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2802%2900046-3

7 January 2021

The Confirmation and Maintenance of Smallpox Eradication

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2802%2900046-3

7 January 2021

Human papillomavirus and cervical carcinogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2802%2900046-3

7 January 2021

The Functions of Human Papillomavirus Type 11 E1, E2, and E2C Proteins in Cell-free DNA Replication

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2802%2900046-3

7 January 2021

Immunology of human papillomavirus infection in lower genital tract neoplasia.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2802%2900046-3

7 January 2021

Cellular immunodeficiency enhances the progression of human papillomavirus-associated cervical lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2802%2900046-3

7 January 2021

Immunity, components of the immune system and immune response

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2802%2900046-3

7 January 2021

The role of human papillomavirus vaccines in cervical neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2802%2900046-3

7 January 2021

Phylogenetic perspectives in innate immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2802%2900046-3

7 January 2021

Innate immunity and the biological relevance of the acquired immune response

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2802%2900046-3

7 January 2021

The toll of innate immunity on microbial pathogens

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2802%2900046-3

7 January 2021

Dendritic cells: a link between innate and adaptive immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2802%2900046-3

7 January 2021

Overview of vaccinology with special reference to papillomavirus vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2802%2900046-3

7 January 2021

The immune system evolved to discriminate infectious nonself from noninfectious self

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2802%2900046-3

7 January 2021

Tolerance, danger, and the extended family

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2802%2900046-3

7 January 2021

An innate sense of danger

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2802%2900046-3

7 January 2021

Papillomavirus-like particle vaccines for cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2802%2900046-3

7 January 2021

The natural history of human papillomavirus type 16 capsid antibodies among a cohort of university women.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2802%2900046-3

7 January 2021

Cervical dysplasia in HIV-seropositive women: role of human papillomavirus infection and immune status

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2802%2900046-3

7 January 2021

Natural HPV immunity and vaccination strategies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2802%2900046-3

7 January 2021

The human papillomavirus E7 oncoprotein abrogates signaling mediated by interferon-alpha.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2802%2900046-3

7 January 2021

Comparison of papillomavirus and immunodeficiency virus evolutionary patterns in the context of a papillomavirus vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2802%2900046-3

7 January 2021

Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2802%2900046-3

7 January 2021

Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2802%2900046-3

7 January 2021

Potential strategies utilised by papillomavirus to evade host immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2802%2900046-3

7 January 2021

Origins and evolution of AIDS viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2802%2900046-3

7 January 2021

Development and assessment of a general theory of cervical carcinogenesis utilizing a severe combined immunodeficiency murine-human xenograft model

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2802%2900046-3

7 January 2021

Human papillomavirus and cancer: the epidemiological evidence

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2802%2900046-3

7 January 2021

Analysis of human genital warts (condylomata acuminata) and other genital tumors for human papillomavirus type 6 DNA

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2802%2900046-3

7 January 2021

Human papillomavirus types 6 and 11 DNA sequences in genital and laryngeal papillomas and in some cervical cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2802%2900046-3

7 January 2021

A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2802%2900046-3

7 January 2021

A new type of papillomavirus DNA, its presence in genital cancer biopsies and in cell lines derived from cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2802%2900046-3

7 January 2021

Structure and transcription of human papillomavirus sequences in cervical carcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2802%2900046-3

7 January 2021

Papillomaviruses in human cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2802%2900046-3

7 January 2021

Robert Koch (1843--1910): founder of the science of bacteriology and discoverer of the tubercle bacillus. A study of his life and work

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2802%2900046-3

7 January 2021

INFECTIOUS PAPILLOMATOSIS OF RABBITS : WITH A NOTE ON THE HISTOPATHOLOGY

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2802%2900046-3

7 January 2021

THE PROGRESSION TO CARCINOMA OF VIRUS-INDUCED RABBIT PAPILLOMAS (SHOPE)

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2802%2900046-3

7 January 2021

Human papillomavirus is a necessary cause of invasive cervical cancer worldwide

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2802%2900046-3

7 January 2021

Natural history of cervicovaginal papillomavirus infection in young women.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2802%2900046-3

7 January 2021

A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2802%2900046-3

7 January 2021

The presence of persistent high-risk HPV genotypes in dysplastic cervical lesions is associated with progressive disease: natural history up to 36 months

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2802%2900046-3

7 January 2021

Detection of human papillomavirus DNA in cytologically normal women and subsequent cervical squamous intraepithelial lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2802%2900046-3

7 January 2021

Population-based study of human papillomavirus infection and cervical neoplasia in rural Costa Rica

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2802%2900046-3

7 January 2021

Trends in mortality from cervical cancer in the Nordic countries: association with organised screening programmes

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2802%2900046-3

7 January 2021

Effect of organized screening on the risk of cervical cancer. Evaluation of screening activity in Iceland, 1964-1991

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2802%2900046-3

7 January 2021

A case-control study of cervical cancer screening in north east Scotland.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2802%2900046-3

7 January 2021

Clinical studies of human papilloma vaccines in pre-invasive and invasive cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2802%2900046-3

7 January 2021

Survival of European women with gynaecological tumours, during the period 1978-1989. EUROCARE Working Group

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2802%2900046-3

7 January 2021

Public health paradoxes and the epidemiological impact of an HPV vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2802%2900046-3

7 January 2021

Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2802%2900046-3

7 January 2021

Human papillomavirus (HPV) type 11 recombinant virus-like particles induce the formation of neutralizing antibodies and detect HPV-specific antibodies in human sera

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2802%2900046-3

7 January 2021

Protection against papillomavirus with a polynucleotide vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2802%2900046-3

7 January 2021

Prospects for a vaccine against human papillomavirus

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2802%2900046-3

7 January 2021

Immunology of papillomavirus infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2802%2900046-3

7 January 2021

Is vaccination against human papillomavirus a possibility?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2802%2900046-3

7 January 2021

Chimeric papillomavirus virus-like particles elicit antitumor immunity against the E7 oncoprotein in an HPV16 tumor model

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2802%2900046-3

7 January 2021

Human papillomavirus vaccines for cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2802%2900046-3

7 January 2021

Prerequisites for human papillomavirus vaccine trial: results of feasibility studies.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2802%2900046-3

7 January 2021

Immunization against human papillomavirus infection and associated neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2802%2900046-3

7 January 2021

Immunization with viruslike particles from cottontail rabbit papillomavirus (CRPV) can protect against experimental CRPV infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2802%2900046-3

7 January 2021

The open reading frame L2 of cottontail rabbit papillomavirus contains antibody-inducing neutralizing epitopes

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2802%2900046-3

7 January 2021

Virus-like particles of bovine papillomavirus type 4 in prophylactic and therapeutic immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2802%2900046-3

7 January 2021

Systemic immunization with papillomavirus L1 protein completely prevents the development of viral mucosal papillomas

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2802%2900046-3

7 January 2021

Developing HPV virus-like particle vaccines to prevent cervical cancer: a progress report

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2802%2900046-3

7 January 2021

Safety and immunogenicity trial in adult volunteers of a human papillomavirus 16 L1 virus-like particle vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2802%2900046-3

7 January 2021

HPV DNA testing in cervical cancer screening: results from women in a high-risk province of Costa Rica

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2802%2900046-3

7 January 2021

Evaluating cervical cancer screening programmes for developing countries

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2802%2900046-3

7 January 2021

Nutrition and cervical neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2802%2900046-3

7 January 2021

Carotenoids: biology and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2802%2900046-3

7 January 2021

Nutritional epidemiology of cervical neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2802%2900046-3

7 January 2021

A case-control study of nutrient status and invasive cervical cancer. II. Serologic indicators

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2802%2900046-3

7 January 2021

Nutrients in diet and plasma and risk of in situ cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2802%2900046-3

7 January 2021

Premalignant lesions: role of antioxidant vitamins and beta-carotene in risk reduction and prevention of malignant transformation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2802%2900046-3

7 January 2021

Growth retardation in human cervical dysplasia-derived cell lines by beta-carotene through down-regulation of epidermal growth factor receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2802%2900046-3

7 January 2021

The effect of beta-carotene on the regression and progression of cervical dysplasia: a clinical experiment

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2802%2900046-3

7 January 2021

Effects of beta-carotene and other factors on outcome of cervical dysplasia and human papillomavirus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2802%2900046-3

7 January 2021

beta-Carotene and cervical dysplasia trials in Australia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2802%2900046-3

7 January 2021

Folate deficiency and cervical dysplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2802%2900046-3

7 January 2021

Folate deficiency in rats induces DNA strand breaks and hypomethylation within the p53 tumor suppressor gene

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2802%2900046-3

7 January 2021

Effect of folate on cervical cancer. Synergism among risk factors

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2802%2900046-3

7 January 2021

Vitamin E supplementation and in vivo immune response in healthy elderly subjects. A randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2802%2900046-3

7 January 2021

Vegetables, fruit, and cancer prevention: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2802%2900046-3

7 January 2021

Prevention of cervix cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2802%2900046-3

7 January 2021

Chemoprevention: general perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2802%2900046-3

7 January 2021

Enhancement of regression of cervical intraepithelial neoplasia II (moderate dysplasia) with topically applied all-trans-retinoic acid: a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2802%2900046-3

7 January 2021

Polyamines as biomarkers of cervical intraepithelial neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2802%2900046-3

7 January 2021

10.1016/S0889-8545(02)00046-3

Identifiers

DOI

1 reference

5 August 2017

1 reference